MIP Discovery raises £7 million to advance cell and gene therapy solutions
MIP Discovery, a biotechnology company that develops non-biological affinity reagents for cell and gene therapy applications, has secured a £7 million Series A funding round...
Toragen Inc. appoints Dr. Sandra Coufal as CEO
SAN DIEGO: Toragen Inc., a biotechnology company, announced that Dr. Sandra Coufal, M.D. will join Toragen as its new CEO. Dr. Coufal brings over 30...
Glow LifeTech to commence trading on CSE on March 15
TORONTO: Glow LifeTech Corp. (formerly Ateba Resources Inc.) will commence trading on the Canadian Securities Exchange (CSE) effective at the open of business on March...
Charles River Laboratories Inc.
Charles River Laboratories Inc., is an American corporation specializing in a variety of preclinical and clinical laboratory services for the pharmaceutical, medical device and biotechnology...
Moderna and Lonza announce strategic collaboration to manufacture vaccine against Novel Coronavirus
BASEL, SWITZERLAND: Moderna Inc., a clinical stage biotechnology company, and Lonza Ltd. have announced a 10-year strategic collaboration agreement to enable larger scale manufacture of...